Patent Terms Extended Less Than 35 U.S.C. 156 Certificates extending the terms of the following patents were issued on July 15, 1998. U.S. Patent No. 4,254,129; Granted March 3, 1981, to Albert A. Carr et al.; Owner of Record: Merrell Pharmaceuticals; Title: Piperidine Derivatives; Classification: 514/317; Product Trade Name: ALLEGRA ; Original Expiration Date: April 10, 1999; Term Extended: 679 days. U.S. Patent No. 4,260,769; Granted April 7, 1981, to Valentino J. Stella et al.; Owner of Record: Merck & Co., Inc.; Title: 5,5-Diphenylhydantoins; Classification: 548/112; Product Trade Name: CEREBYX (fosphenytoin sodium); Original Expiration Date: April 7, 1998; Term Extended: Five years. U.S. Patent No. 4,639,436; Granted January 27, 1987, to Bodo Junge et al.; Owner of Record: Bayer AG; Title: Antidiabetic 3,4,5-Trihydroxypiperidines; Classification: 514/24; Product Trade Name: GLYSET (Miglitol); Original Expiration Date: January 27, 2004; Term Extended: Five years. U.S. Patent No. 4,670,444; Granted June 2, 1987, to Klaus Grohe et al.; Owner of Record: Bayer Aktiengesellschaft; Title: 7-Amino-l-Cyclopropyl-4-Oxo-1,4-Dihydro-Quinoline-and Naphthyridine-3-Carboxylic Acids and Antibacterial Agents Containing These Compounds; Classification: 514/300; Product Trade Name: BAYTRIL (enrofloxacin); Original Expiration Date: December 9, 2003; Term Extended: Three years. U.S. Patent No. 4,681,893; Granted July 21, 1987, to Bruce D. Roth; Owner of Record: Wamer-Lambert Company; Title: Trans-6-[2-(3- or 4-Carboxamido-Substituted Pyrrol-1-Yl)Alkyl]-4-Hydroxypyran-2-One Inhibitors of Cholesterol Synthesis; Classification: 514/422; Product Trade Name: LIPITOR (atorvastatin calcium); Original Expiration Date: May 30, 2006; Term Extended: 1,213 days. U.S. Patent No. 4,689,339; Granted August 25, 1987, to Arto J. Karjalainen et al.; Owner of Record: Orion-Yhtyma Oy; Title: 4-Dihydroinden-2-YL-,4-Tetrahydronaphth-2-YL-, And 4-Dihydrobenzofuran-2-Ylimidazoles, Useful to Block 2-Andrenergic Receptors; Classification: 514/396; Product Trade Name: ANTISEDAN (atipamezole hydrochloride); Original Expiration Date: November 21, 2005; Term Extended: 1,719 days. U.S. Patent No. 4,861,584; Granted August 29, 1989, to Thomas W. Powell, Jr. et al.; Owner of Record: United Catalysts, Inc.; Title: Allergen Absorbent and Blocking Aerosol Composition; Classification: 424/79; Product Trade Name: IVY BLOCK (bentoquatam); Original Expiration Date: August 29, 2006; Term Extended: 1,458 days. U.S. Patent No. 4,902,683; Granted February 20, 1990, to Amin et al.; Owner of Record: Pharmacia & Upjohn Company; Title: Crystalline Cephalosporin Hydrohalide Salts; Classification: 514/206; Product Trade Name: EXCENEL Sterile Suspension; Original Expiration Date: February 20, 2007; Term Extended: 460 days. Certificates extending the terms of the following patents were issued on September 15, 1997: U.S. Patent No. 4,406,899; Granted September 27, 1983, to Shimpei Aburaki et al.; Owner of Record: Bristol-Myers Company; Title: Cephalosporins; Classification: 424/246; Product Trade Name: MAXIPIME (cefepime hydrochloride); Original Expiration Date: March 4, 2002; Term Extended: Five years. U.S. Patent No. 4,544,664; Granted October 1, 1985, to Arto J. Karjalainen et al.; Owner of Record: Orion-Yhtyma Oy; Title: Antihypertensive Substituted Imidazole Derivatives; Classification: 514/396; Product Trade Name: DOMITOR (medetomidine hydrochloride); Original Expiration Date: February 11, 2001; Term Extended: Three years. U.S. Patent No. 4,686,214; Granted August 11, 1987, to John J. Boltralik; Owner of Record: Alcon Laboratories, Inc.; Title: Anti-Inflammatory Compounds for Ophthalmic Use; Classification: 514/179; Product Trade Name: VEXOL (rimexolone); Original Expiration Date: October 30, 2005; Term Extended: 996 days; Expiration Date of Extension: July 22, 2008. U.S. Patent No. 5,045,302; Granted September 3, 1991, to James D. Kelly et al.; Owner of Record: Amersham International plc.; Title: Ligands and Cationic Complexes Thereof with Technetium-99M; Classification: 424/1.1; Product Trade Name: MYOVIEW (technetium tc99m tetrofosmin); Original Expiration Date: October 6, 2008; Term Extended: 491 days; Expiration Date of Extension: February 9, 2010.